{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T08:44:43Z","timestamp":1749458683720},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T00:00:00Z","timestamp":1509321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s10549-017-4551-7","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T08:21:36Z","timestamp":1509351696000},"page":"697-702","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The yield of targeted genotyping for the recurring mutations in BRCA1\/2 in Israel"],"prefix":"10.1007","volume":"167","author":[{"given":"Rinat","family":"Bernstein-Molho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael","family":"Laitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagit","family":"Schayek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orit","family":"Reish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shira","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Haim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal","family":"Zidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eitan","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,30]]},"reference":[{"key":"4551_CR1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","volume":"91","author":"E Warner","year":"1999","unstructured":"Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C et al (1999) Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91:1241\u20131247","journal-title":"J Natl Cancer Inst"},{"key":"4551_CR2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/gyno.2000.5848","volume":"78","author":"DH Tobias","year":"2000","unstructured":"Tobias DH, Eng C, McCurdy LD, Kalir T, Mandelli J, Dottino PR et al (2000) Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients. Gynecol Oncol 78:148\u2013151","journal-title":"Gynecol Oncol"},{"key":"4551_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/gte.1997.1.47","volume":"1","author":"M Robson","year":"1997","unstructured":"Robson M, Dabney MK, Rosenthal G, Ludwig S, Seltzer MH, Gilewski T et al (1997) Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. Genet Test 1:47\u201351","journal-title":"Genet Test"},{"key":"4551_CR4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1086\/301924","volume":"63","author":"I Lerer","year":"1998","unstructured":"Lerer I, Wang T, Peretz T, Sagi M, Kaduri L, Orr-Urtreger A et al (1998) The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction. Am J Hum Genet 63:272\u2013274","journal-title":"Am J Hum Genet"},{"key":"4551_CR5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000051156","volume":"4","author":"R Shiri-Sverdlov","year":"2001","unstructured":"Shiri-Sverdlov R, Gershoni-Baruch R, Ichezkel-Hirsch G, Gotlieb WH, Bar-Sade RB, Chetrit A et al (2001) The Tyr978X BRCA1 mutation in non-Ashkenazi Jews: occurrence in high-risk families, general population and unselected ovarian cancer patients. Public Health Genomics 4:50\u201355","journal-title":"Public Health Genomics"},{"key":"4551_CR6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s10549-012-2006-8","volume":"133","author":"Y Laitman","year":"2012","unstructured":"Laitman Y, Simeonov M, Herskovitz L, Kushnir A, Shimon-Paluch S, Kaufman B et al (2012) Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel. Breast Cancer Res Treat 133:1153\u20131157","journal-title":"Breast Cancer Res Treat"},{"key":"4551_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10689-010-9395-9","volume":"10","author":"M Sagi","year":"2011","unstructured":"Sagi M, Eilat A, Avi LB, Goldberg Y, Bercovich D, Hamburger T et al (2011) Two BRCA1\/2 founder mutations in Jews of Sephardic origin. Fam Cancer 10:59\u201363","journal-title":"Fam Cancer"},{"key":"4551_CR8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10549-010-1217-0","volume":"127","author":"Y Laitman","year":"2011","unstructured":"Laitman Y, Borsthein RT, Stoppa-Lyonnet D, Dagan E, Castera L, Goislard M et al (2011) Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel. Breast Cancer Res Treat 127:489\u2013495","journal-title":"Breast Cancer Res Treat"},{"key":"4551_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","volume":"62","author":"G Parmigiani","year":"1998","unstructured":"Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145\u2013158","journal-title":"Am J Hum Genet"},{"key":"4551_CR10","unstructured":"The Penn II Risk model, BRCA 1 and BRCA 2 mutation predictor. https:\/\/pennmodel2.pmacs.upenn.edu\/penn2\/index.jsp . Accessed 2 Sep 2017"},{"key":"4551_CR11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/bjc.2013.730","volume":"110","author":"AJ Lee","year":"2014","unstructured":"Lee AJ, Cunningham AP, Kuchenbaecker KB, Mavaddat N, Easton DF, Antoniou AC (2014) BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface. Br J Cancer 110:535\u2013545","journal-title":"Br J Cancer"},{"key":"4551_CR12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cancergen.2015.11.003","volume":"209","author":"H Schayek","year":"2016","unstructured":"Schayek H, De Marco L, Starinsky-Elbaz S, Rossette M, Laitman Y, Bastos-Rodrigues L et al (2016) The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil. Cancer Genet 209:50\u201352","journal-title":"Cancer Genet"},{"key":"4551_CR13","doi-asserted-by":"publisher","DOI":"10.2174\/1874220301401010031","author":"A Zick","year":"2015","unstructured":"Zick A, Cohen S, Hamburger T, Goldberg Y, Zvi N, Sagi M et al (2015) A BRCA1 frame shift mutation in women of Kurdish Jewish descent. Open Med J. https:\/\/doi.org\/10.2174\/1874220301401010031","journal-title":"Open Med J"},{"key":"4551_CR14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10689-016-9951-z","volume":"16","author":"A Zick","year":"2017","unstructured":"Zick A, Kadouri L, Cohen S, Frohlinger M, Hamburger T, Zvi N et al (2017) Recurrent TP53 missense mutation in cancer patients of Arab descent. Fam Cancer 16:295\u2013301","journal-title":"Fam Cancer"},{"key":"4551_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4474-3","author":"J Zidan","year":"2017","unstructured":"Zidan J, Zhou AY, van den Akker J, Laitman Y, Schayek H, Schnaider J et al (2017) Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel. Breast Cancer Res Treat. https:\/\/doi.org\/10.1007\/s10549-017-4474-3","journal-title":"Breast Cancer Res Treat"},{"key":"4551_CR16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/hmg\/ddi052","volume":"14","author":"A Shaag","year":"2005","unstructured":"Shaag A, Walsh T, Renbaum P, Kirchhoff T, Nafa K, Shiovitz S et al (2005) Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population. Hum Mol Genet 14:555\u2013563","journal-title":"Hum Mol Genet"},{"key":"4551_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.1996","author":"T Walsh","year":"2017","unstructured":"Walsh T, Mandell JB, Norquist BM, Casadei S, Gulsuner S, Lee MK et al (2017) Genetic predisposition to breast cancer due to mutations other than BRCA1 and BRCA2 founder alleles among Ashkenazi Jewish women. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2017.1996","journal-title":"JAMA Oncol"},{"key":"4551_CR18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","volume":"1","author":"R Janavi\u010dius","year":"2010","unstructured":"Janavi\u010dius R (2010) Founder BRCA1\/2 mutations in the Europe: implications for hereditary breast\u2013ovarian cancer prevention and control. EPMA J 1:397\u2013412","journal-title":"EPMA J"},{"key":"4551_CR19","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1001\/jama.297.23.2587","volume":"297","author":"JN Weitzel","year":"2007","unstructured":"Weitzel JN, Lagos VI, Cullinane CA, Gambol PJ, Culver JO, Blazer KR et al (2007) Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297:2587\u20132595","journal-title":"JAMA"},{"key":"4551_CR20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"M-C King","year":"2003","unstructured":"King M-C, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643\u2013646","journal-title":"Science"},{"key":"4551_CR21","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/302320","volume":"64","author":"P Hartge","year":"1999","unstructured":"Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA (1999) The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet 64:963\u2013970","journal-title":"Am J Hum Genet"},{"key":"4551_CR22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K et al (2015) Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121:25\u201333","journal-title":"Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4551-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T09:33:01Z","timestamp":1570267981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4551-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,30]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["4551"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4551-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,30]]}}}